EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial

Mohamed A ElLaboudy, Maha M Saber, Amira A Adly, Eman A Ismail, Fatma A Ibrahim, Omar M Elalfy

Clinical Nutrition · 2025

DOI: 10.1016/j.clnu.2025.05.003 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Mohamed A ElLaboudy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: beta-Thalassemia, Vitamin E, Iron Overload, Oxidative Stress. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Ain Shams University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Vitamin E is an anti-oxidant depleted in thalassemia as a result of iron overload. AIM: We investigated the efficacy and safety of vitamin E as an adjuvant therapy to iron chelators in transfusion-dependent thalassemia patients in relation to tissue iron overload and examine its potential corrective value to oxidative stress markers including peroxiredoxin-2 (PRDX2). METHODS: This randomized prospective study included 180 pediatric patients with transfusion-dependent β-thalassemia who were equally divided into three groups to either receive desferrioxamine (DFO), deferiprone (DFP) or deferasirox (DFX). Patients in each group were further randomized to receive vitamin E supplementation (400 mg daily) or matching placebo. Patients were followed-up for 12 months with assessment of oxidative stress markers (malondialdehyde [MDA], reduced glutathione, superoxide dismutase, glutathione peroxidase and PRDX2), serum ferritin (SF), liver iron content (LIC) and cardiac T2∗ by magnetic resonance imaging. The primary endpoint was the change between groups from baseline to 12 months as regards LIC. RESULTS: After vitamin E therapy, transfusion index, SF and LIC were significantly decreased while hemoglobin and cardiac T2∗ were elevated compared with baseline levels or placebo group. MDA levels were decreased while the studied antioxidants were improved after vitamin E supplementation compared with baseline levels or placebo. DFX-treated patients had the highest hemoglobin level with the lowest SF, LIC and MDA levels compared with DFO or DFP subgroups. CONCLUSIONS: Vitamin E is a safe adjuvant anti-oxidant therapy that potentiates the efficacy of DFX in reducing iron burden in transfusion-dependent β-thalassemia patients. This trial was registered under ClinicalTrials.gov Identifier no. NCT06509581.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaVitamin EIron OverloadOxidative StressIron Chelating AgentsDietary SupplementsHumansMaleFemaleChildBiomarkersProspective StudiesDeferoxamineChild, PreschoolDeferasiroxAdolescentAntioxidantsLiverIronDeferiproneBlood TransfusionTreatment OutcomePyridonesFerritins

Stichwörter der Autor:innen

Oxidative stressPeroxiredoxin-2Tissue iron overloadTransfusion-dependent thalassemiaVitamin E

Substanzen

Vitamin EIron Chelating AgentsBiomarkersDeferoxamineDeferasiroxAntioxidantsIronDeferipronePyridonesFerritins

Autor:innen und Institutionen

  • Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Complementary Medicine Department, National Research Center, Cairo, Egypt.
  • Pediatrics Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: amiradiabetes@yahoo.com.
  • Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
  • Biochemistry Department, National Research Center, Cairo, Egypt.

Förderung

  • Ain Shams University

Zitieren

APA

ElLaboudy, M. A., Saber, M. M., Adly, A. A., Ismail, E. A., Ibrahim, F. A., & Elalfy, O. M. (2025). Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.05.003

Vancouver

ElLaboudy MA, Saber MM, Adly AA, Ismail EA, Ibrahim FA, Elalfy OM. Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.05.003

BibTeX
@article{ElLaboudy2025,
  author = {ElLaboudy, Mohamed A and Saber, Maha M and Adly, Amira A and Ismail, Eman A and Ibrahim, Fatma A and Elalfy, Omar M},
  title = {Oxidative stress markers and tissue iron overload after 12-months vitamin E supplementation for children with transfusion-dependent β-thalassemia on different iron chelators: A randomized placebo-controlled trial},
  journal = {Clinical Nutrition},
  year = {2025},
  doi = {10.1016/j.clnu.2025.05.003}
}
Kostenlos starten →